Extrathoracic tuberculosis lymphadenitis in adult HIV seronegative patients: A population-based analysis in Houston, Texas, USA

International Journal of Tuberculosis and Lung Disease

Volumn 7, Issue 10, 2003, Pages 987-993

  Gonzalez, Omar Y ^a   Teeter, L D ^a   Thanh, B T ^a   Musser, J M ^b   Graviss, E A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Extra pulmonary tuberculosis; Mycobacterium tuberculosis; Tuberculosis lymphadenitis

Indexed keywords

ADULT; AGE; ARTICLE; ASIAN; BACTERIUM ISOLATE; BCG VACCINATION; COVARIANCE; DEMOGRAPHY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; GENDER; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMIGRANT; INCIDENCE; INTERVIEW; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES;

ADULT; FEMALE; HIV SERONEGATIVITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TEXAS; TUBERCULOSIS, LYMPH NODE;

EID: 0141929333     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Mandell G L, Bennett J E, Dolin R. Mycobacterial diseases. In: Livingstone C, editor. Principles and Practice of Infectious Diseases. Fifth ed. Philadelphia: Churchill Livingstone; 2000. pp 2597-2607.
2. Fanning A. Tuberculosis: 6. Extrapulmonary disease. CMAJ 1999; 160: 1597-1603.
3. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000; 161 (4 Pt 1): 1376-1395.
4. Surveillance Report: Reported Tuberculosis in the United States, 2001. In: Center for Disease Control and Prevention; 2001.
5. Surveillance Report: Reported Tuberculosis in the United States, 2000. In: Center for Disease Control and Prevention; 2000.
6. Barnes P F, Bloch A B, Davidson P T, Snider D E Jr. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991; 324: 1644-1650.
7. Chaisson R E, Schecter G F, Theuer C P, Rutherford G W, Echenberg D F, Hopewell P C. Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis 1987; 136: 570-574.
8. Slutsker L, Castro K G, Ward J W, Dooley S W Jr. Epidemiology of extrapulmonary tuberculosis among persons with AIDS in the United States. Clin Infect Dis 1993; 16: 513-518.
9. Snider D E Jr. Extrapulmonary tuberculosis in Oklahoma, 1965 to 1973. Am Rev Respir Dis 1975; 111: 641-646.
10. Farer L S, Lowell A M, Meador M P. Extrapulmonary tuberculosis in the United States. Am J Epidemiol 1979; 109: 205-217.
11. Mehra J B, Kasprzyk D, Harvill L M, Anderson H R. Extrapulmonary tuberculosis in Tennessee from 1977-1981. A review of statistical analysis. J Tenn Med Assoc 1985; 78: 271-275.
12. Weir M R, Thornton G F. Extrapulmonary tuberculosis. Experience of a community hospital and review of the literature. Am J Med 1985; 79: 467-478.
13. Rieder H L, Snider D E Jr, Cauthen G M. Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis 1990; 141:347-351.
14. Elder N C. Extrapulmonary tuberculosis. A review. Arch Fam Med 1992; 1: 91-98.
15. McMaster P, Isaacs D. Critical review of evidence for short course therapy for tuberculous adenitis in children. Pediatr Infect Dis J 2000; 19: 401-404.
16. Shriner K A, Mathisen G E, Goetz M B. Comparison of mycobacterial lymphadenitis among persons infected with human immunodeficiency virus and seronegative controls. Clin Infect Dis 1992; 15: 601-605.
17. Artenstein A W, Kim J H, Williams W J, Chung R C. Isolated peripheral tuberculous lymphadenitis in adults: current clinical and diagnostic issues. Clin Infect Dis 1995; 20: 876-882.
18. Ehlers S, Ignatius R, Regnath T, Hahn H. Diagnosis of extrapulmonary tuberculosis by Gen-Probe amplified Mycobacterium tuberculosis direct test. J Clin Microbiol 1996; 34: 2275-2279.
19. Almeda J, Garcia A, Gonzalez J, et al. Clinical evaluation of an in-house IS6110 polymerase chain reaction for diagnosis of tuberculosis. Eur J Clin Microbiol Infect Dis 2000; 19: 859-867.
20. Goyal M, Saunders N A, van Embden J D, Young D B, Shaw R J. Differentiation of Mycobacterium tuberculosis isolates by spoligotyping and IS6110 restriction fragment length polymorphism. J Clin Microbiol 1997; 35: 647-651.
21. World Health Organization. Abbreviations, acronyms and WHO regions. In: http: //www.who.int/medicines/strategy/whozip16e/ch02.htm; 2002.
22. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282: 677-686.
23. Mehta J B, Dutt A, Harvill L, Mathews K M. Epidemiology of extrapulmonary tuberculosis. A comparative analysis with pre-AIDS era. Chest 1991; 99: 1134-1138.
24. Richter C, Koelemay M J, Swai A B, Perenboom R, Mwakyusa D H, Oosting J. Predictive markers of survival in HIV-seropositive and HIV-seronegative Tanzanian patients with extrapulmonary tuberculosis. Tubercle Lung Dis 1995; 76: 510-517.
25. Dandapat M C, Mishra B M, Dash S P, Kar P K. Peripheral lymph node tuberculosis: a review of 80 cases. Br J Surg 1990; 77:911-912.
26. Kent D C. Tuberculous lymphadenitis: not a localized disease process. Am J Med Sci 1967; 254: 866-874.
27. Chen Y M, Lee P Y, Su W J, Perng R P. Lymph node tuberculosis: 7-year experience in Veterans General Hospital, Taipei, Taiwan. Tubercle Lung Dis 1992; 73: 368-371.
28. Walker W, Roberts C W, Ferguson D J, Jebbari H, Alexander J. Innnate immunity to Toxoplasma gondii is influenced by gender and is associated with differences in interleukin-12 and gamma interferon production. Infect Immun 1997; 65: 1119-1121.
29. Roberts C W, Walker W, Alexander J. Sex-associated hormones and immunity to protozoan parasites. Clin Microbiol Rev 2001; 14: 476-488.
30. Aguilar-Delfin I, Homer M J, Wettstein P J, Persing D H. Innate resistance to Babesia infection is influenced by genetic background and gender. Infect Immun 2001; 69: 7955-2958.
31. El Sahly H M, Adams G J, Soini H, Teeter L, Musser J M, Graviss E A. Epidemiologic differences between United States-and foreign-born tuberculosis patients in Houston, Texas. J Infect Dis 2001; 183: 461-468.